돼지 써코바이러스 타입 1 및 2의 감별진단을 위한미니어레이법
    21.
    发明公开
    돼지 써코바이러스 타입 1 및 2의 감별진단을 위한미니어레이법 有权
    PORCINE CIRCOVIRUS类型1和2之间的差异诊断的微型计算

    公开(公告)号:KR1020100004546A

    公开(公告)日:2010-01-13

    申请号:KR1020080064772

    申请日:2008-07-04

    CPC classification number: C12Q1/701 C12Q1/6827

    Abstract: PURPOSE: A method for diagnosing porcine circovirus 1 and 2 from Postweaning Multi-systemic Wasting Sysdrome(PMWS) or Porcine Der- matitis and Nephropathy Syndrome(PDNS) is provided to improve accuracy of diagnosis. CONSTITUTION: A method for diagnosing porcine circovirus type 1 and 2 from Postweaning Multi-systemic Wasting Sysdrome(PMWS) or Porcine Der- matitis and Nephropathy Syndrome(PDNS) comprises: a step of loading DNA and common probe(sequence number 3) of porcine circovirus(sequence number 3) on a nylon membrane; a step of amplifying the DNA isolated from sample of outside; a step of hybridizing PCR amplified product with nylon membrane; a step of dyeing hydridized product with nitrotetrazolium and bromo-chloro-indolyl phosphate; and a step of determining negative or positive.

    Abstract translation: 目的:提供断奶后多系统性挥发性综合征(PMWS)或猪肾炎和肾病综合征(PDNS)诊断猪圆环病毒1和2的方法,以提高诊断的准确性。 构成:从断奶后多系统性挥发性综合征(PMWS)或猪肾炎和肾病综合征(PDNS)中诊断1型和2型猪圆环病毒的方法包括:将DNA和普通探针(序列号3)加载到猪的步骤 圆环病毒(序列号3)在尼龙膜上; 扩增从外部样品分离的DNA的步骤; PCR扩增产物与尼龙膜杂交的步骤; 用硝基四唑和溴 - 氯 - 吲哚基磷酸酯染色杂化产物的步骤; 并确定负面或积极的一个步骤。

    소설사병 바이러스성 원인체의 유전자 진단을 위한 프로브, 프라이머 및 이를 이용한 진단방법
    26.
    发明公开
    소설사병 바이러스성 원인체의 유전자 진단을 위한 프로브, 프라이머 및 이를 이용한 진단방법 有权
    用于NDC病毒病原体基因诊断的探针和引物及使用其的诊断方法

    公开(公告)号:KR1020130058105A

    公开(公告)日:2013-06-04

    申请号:KR1020110123936

    申请日:2011-11-25

    Abstract: PURPOSE: A probe and a gene chip for diagnosing norovirus, rotavirus, and coronavirus, a primer for amplifying a gene, and a method for diagnosing pathogen using the same are provided to detect pathogen causing NCD(Neonatal Calf Diarrhea) and genotype. CONSTITUTION: A primer for detecting rotavirus, norovirus, and coronavirus which are a pathogen causing NCD contains a primer containing one or more sequences among sequence numbers 1-12. A method for amplifying a gene comprises simultaneously detecting rotavirus A, B, and C using a primer containing sequences of sequence numbers 1-6. The method comprises a step of detecting norovirus genotype group I, II, and III using a primer containing sequences of sequence numbers 7-10. The method comprises a step of detecting coronavirus using one or more primers among sequence numbers of sequence numbers 11 and 12. A probe contains one or more sequences among sequence numbers 13-91 to detect rotavirus, norovirus, and coronavirus.

    Abstract translation: 目的:提供用于诊断诺如病毒,轮状病毒和冠状病毒的探针和基因芯片,用于扩增基因的引物和使用其的病原体诊断方法,以检测引起NCD(新生小牛腹泻)和基因型的病原体。 构成:用于检测导致NCD的病原体的轮状病毒,诺如病毒和冠状病毒的引物含有含有序列号1-12中的一个或多个序列的引物。 用于扩增基因的方法包括使用含有序列号1-6的序列的引物同时检测轮状病毒A,B和C. 该方法包括使用含有序列号7-10的序列的引物检测诺如病毒基因型I,II和III的步骤。 该方法包括使用序列号11和12的序列号中的一种或多种引物检测冠状病毒的步骤。探针含有序列号13-91中的一个或多个序列,以检测轮状病毒,诺如病毒和冠状病毒。

    소 타일레리아병의 약독화 백신
    27.
    发明授权
    소 타일레리아병의 약독화 백신 有权
    소타일레리아병의약독화백신

    公开(公告)号:KR100430936B1

    公开(公告)日:2004-05-14

    申请号:KR1020010083879

    申请日:2001-12-24

    Abstract: PURPOSE: An attenuated vaccine prepared by isolating a Theileria sergenti Sungwhan stock from Haemaphysalis longicornis and then attenuating it is provided. The vaccine has recognizable specific protection property and thus can be effectively used in the prevention of bovine theileriosis. CONSTITUTION: An attenuated vaccine is prepared by the steps of: recovering Haemaphysalis longicornis imagoes from bovines infected with theileriosis; infecting a rabbit with the Haemaphysalis longicornis imagoes for 6 to 7 days; and aseptically collecting salivary gland from the collected Haemaphysalis longicornis imagoes. The vaccine is formed into an injectable formulation.

    Abstract translation: 目的:提供一种减毒疫苗,它是通过从长角血蜱Haemaphysalis longicornis中分离泰勒虫(Theileria sergenti Sungwhan),然后减毒来制备的。 该疫苗具有可识别的特异性保护特性,因此可有效用于预防牛泰勒虫病。 组成:减毒疫苗是通过以下步骤制备的:从感染泰勒氏菌病的牛中回收长角血蜱(Haemaphysalis longicornis)成虫; 用长角血蜱成虫感染兔子6至7天; 并从收集的Haemaphysalis longicornis成虫中无菌收集唾液腺。 疫苗形成可注射制剂。

Patent Agency Ranking